BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22001245)

  • 1. Prevalence of mental health disorders among patients with Parkinson's disease in the United Kingdom.
    Potluri R; Natalwala A; Nakajima M; Lavu D; Velho R; Uppal H; Heun R
    J Clin Neurosci; 2011 Dec; 18(12):1746-7. PubMed ID: 22001245
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-morbidity and the frequency of general practitioner consultations in Parkinson's disease in the United Kingdom.
    Hindle JV; Hindle CM; Hobson P
    Mov Disord; 2007 May; 22(7):1054-5. PubMed ID: 17427943
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C; Bijl RV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in a population of Parkinson's disease patients.
    Papapetropoulos S; Singer C
    Eur J Neurol; 2006 Aug; 13(8):e1. PubMed ID: 16879275
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimate of point prevalence of Parkinson's disease induced psychosis in the United States.
    Holt RJ
    Mov Disord; 2008 Sep; 23(12):1788-9. PubMed ID: 18649396
    [No Abstract]   [Full Text] [Related]  

  • 6. The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease.
    Porter B; Macfarlane R; Walker R
    Eur J Neurol; 2008 Jan; 15(1):50-4. PubMed ID: 18042241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.
    Dick FD; De Palma G; Ahmadi A; Scott NW; Prescott GJ; Bennett J; Semple S; Dick S; Counsell C; Mozzoni P; Haites N; Wettinger SB; Mutti A; Otelea M; Seaton A; Söderkvist P; Felice A;
    Occup Environ Med; 2007 Oct; 64(10):666-72. PubMed ID: 17332139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database.
    Makaroff L; Gunn A; Gervasoni C; Richy F
    J Parkinsons Dis; 2011; 1(1):65-74. PubMed ID: 23939257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom.
    Hobson P; Gallacher J; Meara J
    Mov Disord; 2005 Aug; 20(8):995-8. PubMed ID: 15852368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimate of the prevalence of Parkinson's disease by using electronic health archives].
    Tominz R; Marin L; Mezzarobba S
    Recenti Prog Med; 2015 Feb; 106(2):97-102. PubMed ID: 25734600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of cardiovascular disease amongst psychiatric patients between 2001 and 2012 in Greater Manchester, UK.
    Carter P; Rai G; Aziz A; Mann J; Chandran S; Uppal H; Potluri R
    Int J Cardiol; 2014 May; 173(3):573-4. PubMed ID: 24698254
    [No Abstract]   [Full Text] [Related]  

  • 12. How to care for people with Parkinson's disease.
    Cotton P; Heisters D
    Nurs Times; 2012 Apr 17-23; 108(16):12-4. PubMed ID: 22667072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and other movement disorders.
    Chen JJ
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):293. PubMed ID: 20869619
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features associated with impulse control disorders in Parkinson disease.
    Pontone G; Williams JR; Bassett SS; Marsh L
    Neurology; 2006 Oct; 67(7):1258-61. PubMed ID: 17030761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.
    Ghosh B; Mishra A; Sengupta P
    J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health care use in Parkinson's disease: a record linkage study.
    Leentjens AF; Driessen G; Weber W; Drukker M; van Os J
    Neuroepidemiology; 2008; 30(2):71-5. PubMed ID: 18277080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of death in Parkinson's disease.
    Snell K; Pennington S; Lee M; Walker R
    Age Ageing; 2009 Sep; 38(5):617-9. PubMed ID: 19628680
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychiatric morbidity among adults living in private households, 2000.
    Singleton N; Bumpstead R; O'Brien M; Lee A; Meltzer H
    Int Rev Psychiatry; 2003; 15(1-2):65-73. PubMed ID: 12745312
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK.
    Evans JR; Cummins G; Breen DP; Foltynie T; Mason SL; Brayne CE; Williams-Gray CH; Barker RA
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1034-6. PubMed ID: 26800710
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
    Chitnis S
    Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.